table of content
1 Introduction to Research & Analysis Reports
1.1 Tumor NGS Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor NGS Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor NGS Genetic Testing Overall Market Size
2.1 Global Tumor NGS Genetic Testing Market Size: 2023 VS 2030
2.2 Global Tumor NGS Genetic Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor NGS Genetic Testing Players in Global Market
3.2 Top Global Tumor NGS Genetic Testing Companies Ranked by Revenue
3.3 Global Tumor NGS Genetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Tumor NGS Genetic Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Tumor NGS Genetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor NGS Genetic Testing Players in Global Market
3.6.1 List of Global Tier 1 Tumor NGS Genetic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor NGS Genetic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor NGS Genetic Testing Market Size Markets, 2023 & 2030
4.1.2 Liquid Biopsy (Blood Sample)
4.1.3 Tissue Biopsy
4.2 By Type - Global Tumor NGS Genetic Testing Revenue & Forecasts
4.2.1 By Type - Global Tumor NGS Genetic Testing Revenue, 2019-2024
4.2.2 By Type - Global Tumor NGS Genetic Testing Revenue, 2025-2030
4.2.3 By Type - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor NGS Genetic Testing Market Size, 2023 & 2030
5.1.2 Companion Diagnostics
5.1.3 Early Cancer Screening
5.1.4 Drug Discovery
5.2 By Application - Global Tumor NGS Genetic Testing Revenue & Forecasts
5.2.1 By Application - Global Tumor NGS Genetic Testing Revenue, 2019-2024
5.2.2 By Application - Global Tumor NGS Genetic Testing Revenue, 2025-2030
5.2.3 By Application - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Tumor NGS Genetic Testing Market Size, 2023 & 2030
6.2 By Region - Global Tumor NGS Genetic Testing Revenue & Forecasts
6.2.1 By Region - Global Tumor NGS Genetic Testing Revenue, 2019-2024
6.2.2 By Region - Global Tumor NGS Genetic Testing Revenue, 2025-2030
6.2.3 By Region - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Tumor NGS Genetic Testing Revenue, 2019-2030
6.3.2 US Tumor NGS Genetic Testing Market Size, 2019-2030
6.3.3 Canada Tumor NGS Genetic Testing Market Size, 2019-2030
6.3.4 Mexico Tumor NGS Genetic Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Tumor NGS Genetic Testing Revenue, 2019-2030
6.4.2 Germany Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.3 France Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.4 U.K. Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.5 Italy Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.6 Russia Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.7 Nordic Countries Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.8 Benelux Tumor NGS Genetic Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Tumor NGS Genetic Testing Revenue, 2019-2030
6.5.2 China Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.3 Japan Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.4 South Korea Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.5 Southeast Asia Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.6 India Tumor NGS Genetic Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Tumor NGS Genetic Testing Revenue, 2019-2030
6.6.2 Brazil Tumor NGS Genetic Testing Market Size, 2019-2030
6.6.3 Argentina Tumor NGS Genetic Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor NGS Genetic Testing Revenue, 2019-2030
6.7.2 Turkey Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.3 Israel Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.5 UAE Tumor NGS Genetic Testing Market Size, 2019-2030
7 Tumor NGS Genetic Testing Companies Profiles
7.1 Foundation Medicine
7.1.1 Foundation Medicine Company Summary
7.1.2 Foundation Medicine Business Overview
7.1.3 Foundation Medicine Tumor NGS Genetic Testing Major Product Offerings
7.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.1.5 Foundation Medicine Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Tumor NGS Genetic Testing Major Product Offerings
7.2.4 Guardant Health Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Tumor NGS Genetic Testing Major Product Offerings
7.3.4 Illumina Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.3.5 Illumina Key News & Latest Developments
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Company Summary
7.4.2 Thermo Fisher Scientific Inc. Business Overview
7.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.4.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.5 DIAN DIAGNOSTICS Group Co., Ltd.
7.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Summary
7.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
7.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Key News & Latest Developments
7.6 Burning Rock Biotech.
7.6.1 Burning Rock Biotech. Company Summary
7.6.2 Burning Rock Biotech. Business Overview
7.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Major Product Offerings
7.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.6.5 Burning Rock Biotech. Key News & Latest Developments
7.7 NovogeneCo.,Ltd.
7.7.1 NovogeneCo.,Ltd. Company Summary
7.7.2 NovogeneCo.,Ltd. Business Overview
7.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.7.5 NovogeneCo.,Ltd. Key News & Latest Developments
7.8 Nanjing Shihejiyin Technology, Inc.
7.8.1 Nanjing Shihejiyin Technology, Inc. Company Summary
7.8.2 Nanjing Shihejiyin Technology, Inc. Business Overview
7.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Major Product Offerings
7.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.8.5 Nanjing Shihejiyin Technology, Inc. Key News & Latest Developments
7.9 Amoy Diagnostics Co.,Ltd.
7.9.1 Amoy Diagnostics Co.,Ltd. Company Summary
7.9.2 Amoy Diagnostics Co.,Ltd. Business Overview
7.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.9.5 Amoy Diagnostics Co.,Ltd. Key News & Latest Developments
7.10 China National Pharmaceutical Group Corporation
7.10.1 China National Pharmaceutical Group Corporation Company Summary
7.10.2 China National Pharmaceutical Group Corporation Business Overview
7.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Major Product Offerings
7.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.10.5 China National Pharmaceutical Group Corporation Key News & Latest Developments
7.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
7.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Summary
7.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
7.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Key News & Latest Developments
7.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
7.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Summary
7.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
7.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Key News & Latest Developments
7.13 ADICON Clinical Laboratories, Inc.
7.13.1 ADICON Clinical Laboratories, Inc. Company Summary
7.13.2 ADICON Clinical Laboratories, Inc. Business Overview
7.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Major Product Offerings
7.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.13.5 ADICON Clinical Laboratories, Inc. Key News & Latest Developments
7.14 Genetron
7.14.1 Genetron Company Summary
7.14.2 Genetron Business Overview
7.14.3 Genetron Tumor NGS Genetic Testing Major Product Offerings
7.14.4 Genetron Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.14.5 Genetron Key News & Latest Developments
7.15 Genecast Group Inc.
7.15.1 Genecast Group Inc. Company Summary
7.15.2 Genecast Group Inc. Business Overview
7.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Major Product Offerings
7.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.15.5 Genecast Group Inc. Key News & Latest Developments
7.16 BGI Genomics Co.,Ltd.
7.16.1 BGI Genomics Co.,Ltd. Company Summary
7.16.2 BGI Genomics Co.,Ltd. Business Overview
7.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.16.5 BGI Genomics Co.,Ltd. Key News & Latest Developments
7.17 Beijing-Geneplus Technology Limited.
7.17.1 Beijing-Geneplus Technology Limited. Company Summary
7.17.2 Beijing-Geneplus Technology Limited. Business Overview
7.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Major Product Offerings
7.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.17.5 Beijing-Geneplus Technology Limited. Key News & Latest Developments
7.18 Xiamen SpacegenCo., Ltd.
7.18.1 Xiamen SpacegenCo., Ltd. Company Summary
7.18.2 Xiamen SpacegenCo., Ltd. Business Overview
7.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.18.5 Xiamen SpacegenCo., Ltd. Key News & Latest Developments
7.19 Geneis?Beijing?Co.Ltd.
7.19.1 Geneis?Beijing?Co.Ltd. Company Summary
7.19.2 Geneis?Beijing?Co.Ltd. Business Overview
7.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.19.5 Geneis?Beijing?Co.Ltd. Key News & Latest Developments
7.20 HaploX
7.20.1 HaploX Company Summary
7.20.2 HaploX Business Overview
7.20.3 HaploX Tumor NGS Genetic Testing Major Product Offerings
7.20.4 HaploX Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.20.5 HaploX Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
